Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,951.20
(
0.69%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
95.46
(
0.47%
)
Bitcoin
78,272.01
(
2.55%
)
News Focus
News Focus
Post# of 822370
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Steady_T

Send PM Follow Ignore
Followers 169
Posts 23046
Boards Moderated 1
Alias Born 12/09/2004

Steady_T

Member Level

Re: manibiotech post# 774105

Friday, 07/04/2025 1:40:34 AM

Friday, July 04, 2025 1:40:34 AM

Post# of 822370
That question has been discussed multiple times. Have you forgotten?

There is the IPD issue.
There is the lack of production capacity to serve the US market.
There is the lack of funds to pursue multiple drug applications.
And others.

But don't let that stop you from raising the question, over and over again...to what end?

Nunc est Bibendum

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News